SEARCH

SEARCH BY CITATION

References

  • Amir M, Czaja MJ (2011) Autophagy in nonalcoholic steatohepatitis. Expert. Rev. Gastroenterol. Hepatol. 5, 159166.
  • Angulo P (2002) Nonalcoholic fatty liver disease. N. Engl. J. Med. 346, 12211231.
  • Aparicio-Vergara M, Hommelberg PP, Schreurs M, Gruben N, Stienstra R, Shiri-Sverdlov R, Kloosterhuis NJ, de Bruin A, van de Sluis B, Koonen DP, Hofker MH. (2013) Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model. Hepatology 57, 566576.
  • Aravinthan A, Scarpini C, Tachtatzis P, Verma S, Penrhyn-Lowe S, Harvey R, Davies SE, Allison M, Coleman N, Alexander G (2013) Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease. J. Hepatol. 58, 549556.
  • Barzilai N, Ferrucci L (2012) Insulin resistance and aging: a cause or a protective response? J. Gerontol. A Biol. Sci. Med. Sci. 67, 13291331.
  • Blair SN, Kohl HW 3rd, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA (1995) Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA 273, 10931098.
  • Bonomini F, Rodella LF, Moghadasian M, Lonati C, Rezzani R (2013) Apolipoprotein E deficiency and a mouse model of accelerated liver aging. Biogerontology 14, 209220.
  • Booth FW, Laye MJ, Roberts MD (2011) Lifetime sedentary living accelerates some aspects of secondary aging. J. Appl. Physiol. 111, 14971504.
  • Bosch FX, Ribes J, Diaz M, Cleries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127, S5S16.
  • Breitling LP, Raum E, Muller H, Rothenbacher D, Brenner H (2009) Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase. Hepatology 49, 802808.
  • Brown MS, Goldstein JL (2008) Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 7, 9596.
  • Bucher NL, Swaffield MN, Ditroia JF (1964) The Influence of age upon the incorporation of thymidine-2-C14 into the DNA of regenerating rat liver. Cancer Res. 24, 509512.
  • Bugianesi E (2007) Non-alcoholic steatohepatitis and cancer. Clin. Liver Dis. 11, 191207. x-xi
  • Caldwell SH, Crespo DM (2004) The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J. Hepatol. 40, 578584.
  • Chan YC, Suzuki M, Yamamoto S (1999) A comparison of anthropometry, biochemical variables and plasma amino acids among centenarians, elderly and young subjects. J. Am. Coll. Nutr. 18, 358365.
  • Chiu CH, Lin WD, Huang SY, Lee YH (2004) Effect of a C/EBP gene replacement on mitochondrial biogenesis in fat cells. Genes Dev. 18, 19701975.
  • Cohen JC, Horton JD, Hobbs HH (2011) Human fatty liver disease: old questions and new insights. Science 332, 15191523.
  • De Minicis S, Day C, Svegliati-Baroni G (2013) From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights. Curr. Pharm. Des. [Epub ahead of print]
  • El-Serag HB (2011) Hepatocellular carcinoma. N. Engl. J. Med. 365, 11181127.
  • El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142(1264–1273), e1261.
  • Floreani A (2007) Liver diseases in the elderly: an update. Dig. Dis. 25, 138143.
  • Flurkey K, Currer JM, Harrison DE (2007) The Mouse in Aging Research. Burlington: Elsevier.
  • Fontana L, Zhao E, Amir M, Dong H, Tanaka K, Czaja MJ (2013) Aging promotes the development of diet-induced murine steatohepatitis but not steatosis. Hepatology 57, 9951004.
  • Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287, 356359.
  • Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908, 244254.
  • Frith J, Jones D, Newton JL (2009) Chronic liver disease in an ageing population. Age Ageing 38, 1118.
  • Gagliano N, Grizzi F, Annoni G (2007) Mechanisms of aging and liver functions. Dig. Dis. 25, 118123.
  • Gan L, Chitturi S, Farrell GC (2011) Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly. Curr. Gerontol. Geriatr. Res. 2011, 831536.
  • Ghosh PM, Shu ZJ, Zhu B, Lu Z, Ikeno Y, Barnes JL, Yeh CK, Zhang BX, Katz MS, Kamat A (2012) Role of beta-adrenergic receptors in regulation of hepatic fat accumulation during aging. J. Endocrinol. 213, 251261.
  • Guarente L (2011) Franklin H. Epstein Lecture: Sirtuins, aging, and medicine. N. Engl. J. Med. 364, 22352244.
  • Halkidou K, Gaughan L, Cook S, Leung HY, Neal DE, Robson CN (2004) Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate 59, 177189.
  • Harrison SA, Day CP (2007) Benefits of lifestyle modification in NAFLD. Gut 56, 17601769.
  • Honma T, Yanaka M, Tsuduki T, Ikeda I (2011) Increased lipid accumulation in liver and white adipose tissue in aging in the SAMP10 mouse. J. Nutr. Sci. Vitaminol. 57, 123129.
  • Jiang Y, Iakova P, Jin J, Sullivan E, Sharin V, Hong IH, Anakk S, Mayor A, Darlington G, Finegold M, Moore D, Timchenko NA (2013) Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer. Hepatology 57, 10981106.
  • Jin J, Wang GL, Shi X, Darlington GJ, Timchenko NA (2009a) The age-associated decline of glycogen synthase kinase 3beta plays a critical role in the inhibition of liver regeneration. Mol. Cell. Biol. 29, 38673880.
  • Jin J, Wang GL, Timchenko L, Timchenko NA (2009b) GSK3beta and aging liver. Aging 1, 582585.
  • Jin J, Iakova P, Jiang Y, Medrano EE, Timchenko NA (2011) The reduction of SIRT1 in livers of old mice leads to impaired body homeostasis and to inhibition of liver proliferation. Hepatology 54, 989998.
  • Jin J, Iakova P, Breaux M, Sullivan E, Jawanmardi N, Chen D, Jiang Y, Medrano EM, Timchenko NA (2013) Increased expression of enzymes of triglyceride synthesis is essential for the development of hepatic steatosis. Cell Rep. 3, 831843.
  • Katz MS, Dax EM, Gregerman RI (1993) Beta adrenergic regulation of rat liver glycogenolysis during aging. Exp. Gerontol. 28, 329340.
  • Koehler EM, Schouten JN, Hansen BE, van Rooij FJ, Hofman A, Stricker BH, Janssen HL (2012) Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J. Hepatol. 57, 13051311.
  • Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J. 20, 2739.
  • Marchesini G, Bua V, Brunori A, Bianchi G, Pisi P, Fabbri A, Zoli M, Pisi E (1988) Galactose elimination capacity and liver volume in aging man. Hepatology 8, 10791083.
  • McCullough AJ, Raguso C (1999) Effect of cirrhosis on energy expenditure. Am. J. Clin. Nutr. 69, 10661068.
  • Nordenstedt H, White DL, El-Serag HB (2010) The changing pattern of epidemiology in hepatocellular carcinoma. Dig. Liver. Dis. 42(Suppl 3), S206S214.
  • Nosadini R, Avogaro A, Mollo F, Marescotti C, Tiengo A, Duner E, Merkel C, Gatta A, Zuin R, de Kreutzenberg S, Trevisan R, Crepaldi G (1984) Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. J. Clin. Endocrinol. Metab. 58, 11251132.
  • Noureddin M, Yates KP, Vaughn IA, Neuschwander-Tetri BA, Sanyal AJ, McCullough A, Merriman R, Hameed B, Doo E, Kleiner DE, Behling C, Loomba R (2013) Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology. doi: 10.1002/hep.26465.
  • Park H, Ishigami A, Shima T, Mizuno M, Maruyama N, Yamaguchi K, Mitsuyoshi H, Minami M, Yasui K, Itoh Y, Yoshikawa T, Fukui M, Hasegawa G, Nakamura N, Ohta M (2010) Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease. J. Gastroenterol. 45, 426434.
  • Partridge L (2012) Diet and healthy aging. N. Engl. J. Med. 367, 25502551.
  • Pasciu D, Montisci S, Greco M, Doratiotto S, Pitzalis S, Pani P, Laconi S, Laconi E (2006) Aging is associated with increased clonogenic potential in rat liver in vivo. Aging Cell 5, 373377.
  • Pekkanen J, Marti B, Nissinen A, Tuomilehto J, Punsar S, Karvonen MJ (1987) Reduction of premature mortality by high physical activity: a 20-year follow-up of middle-aged Finnish men. Lancet 1, 14731477.
  • Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300, 11401142.
  • Podrini C, Borghesan M, Greco A, Pazienza V, Mazzoccoli G, Vinciguerra M (2013) Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD). Curr. Pharm. Des. 19, 27372746.
  • van der Poorten D, Samer CF, Ramezani-Moghadam M, Coulter S, Kacevska M, Schrijnders D, Wu LE, McLeod D, Bugianesi E, Komuta M, Roskams T, Liddle C, Hebbard L, George J (2012) Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause? Hepatology 57, 21802188.
  • Popper H (1986) Aging and the liver. Prog. Liver Dis. 8, 659683.
  • Premoli A, Paschetta E, Hvalryg M, Spandre M, Bo S, Durazzo M (2009) Characteristics of liver diseases in the elderly: a review. Minerva Gastroenterol. Dietol. 55, 7178.
  • Rappa F, Greco A, Podrini C, Cappello F, Foti M, Bourgoin L, Peyrou M, Marino A, Scibetta N, Williams R, Mazzoccoli G, Federici M, Pazienza V, Vinciguerra M (2013) Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma. PLoS ONE 8, e54458.
  • Regev A, Schiff ER (2001) Liver disease in the elderly. Gastroenterol. Clin. North Am. 30, 547563. x-xi.
  • Rodriguez A, Muller DC, Metter EJ, Maggio M, Harman SM, Blackman MR, Andres R (2007) Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J. Clin. Endocrinol. Metab. 92, 35683572.
  • Sanguino E, Bejarano R, Alegret M, Sanchez RM, Vazquez-Carrera M, Laguna JC (2004) Sexual dimorphism in lipid metabolic phenotype associated with old age in Sprague-Dawley rats. Exp. Gerontol. 39, 12951306.
  • Schmucker DL (2005) Age-related changes in liver structure and function: implications for disease ? Exp. Gerontol. 40, 650659.
  • Slawik M, Vidal-Puig AJ (2006) Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res. Rev. 5, 144164.
  • Smith JR, Pereira-Smith OM (1996) Replicative senescence: implications for in vivo aging and tumor suppression. Science 273, 6367.
  • Stocker E, Heine WD (1971) Regeneration of liver parenchyma under normal and pathological conditions. Beitr. Pathol. 144, 400408.
  • Sun Z, Lazar MA (2013) Dissociating fatty liver and diabetes. Trends Endocrinol. Metab. 24, 412.
  • Tchkonia T, Morbeck DE, Von Zglinicki T, Van Deursen J, Lustgarten J, Scrable H, Khosla S, Jensen MD, Kirkland JL (2010) Fat tissue, aging, and cellular senescence. Aging Cell 9, 667684.
  • Tietz NW, Shuey DF, Wekstein DR (1992) Laboratory values in fit aging individuals–sexagenarians through centenarians. Clin. Chem. 38, 11671185.
  • Tilg H, Moschen AR (2008) Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol. Metab. 19, 371379.
  • Timchenko NA (2009) Aging and liver regeneration. Trends Endocrinol. Metab. 20, 171176.
  • Tomas-Loba A, Bernardes de Jesus B, Mato JM, Blasco MA (2013) A metabolic signature predicts biological age in mice. Aging Cell 12, 93101.
  • Tran TT, Yamamoto Y, Gesta S, Kahn CR (2008) Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab. 7, 410420.
  • Venook AP, Papandreou C, Furuse J, de Guevara LL (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15(Suppl 4), 513.
  • Vestal RE, Wood AJ (1980) Influence of age and smoking on drug kinetics in man: studies using model compounds. Clin. Pharmacokinet. 5, 309319.
  • Vinciguerra M (2012) Old age and steatohepatitis: a dangerous liaison? Hepatology. doi: 10.1002/hep.26212.
  • Wang GL, Iakova P, Wilde M, Awad S, Timchenko NA (2004) Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity. Genes Dev. 18, 912925.
  • WHO (2002). The European Health Report. In European Series n97. Geneva, Switzerland: World Health Organization.
  • WHO (2009). 2008–2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. Geneva, Switzerland: World Health Organization.
  • Willis-Martinez D, Richards HW, Timchenko NA, Medrano EE (2010) Role of HDAC1 in senescence, aging, and cancer. Exp. Gerontol. 45, 279285.
  • Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OF (1989) The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 9, 297301.